Nama Insights

Danaher Corporation (DHR)

Healthcare · Diagnostics Research · NYSE

S&P 500
Danaher Corporation (DHR) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $155.42B, a trailing price-to-earnings ratio of 27.2 and a free-cash-flow yield of 3.3%. Over the most recent reported fiscal year, revenue grew 2.9% and free cash flow per share grew 2.2%.
Market cap$155.42B
Trailing P/E27.2
FCF yield3.3%
Revenue growth (YoY)+2.9%
EPS growth (YoY)+4.1%
FCF/share growth (YoY)+2.2%
ExchangeNYSE
SectorHealthcare
IndustryDiagnostics Research
Explore live DHR data on Nama Insights →

Recent Congressional trades

Danaher Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Alan Armstrong Senate Buy $1,001 - $15,000 Jul 21, 2026
Alan Armstrong Senate Buy $1,001 - $15,000 Jul 21, 2026
Julie Johnson House Sell $1,001 - $15,000 Jan 15, 2026
Julia Letlow House Buy $1,001 - $15,000 Jan 13, 2026
Julie Johnson House Sell $1,001 - $15,000 Dec 11, 2025
Julie Johnson House Buy $1,001 - $15,000 Nov 14, 2025
Lisa McClain House Sell $1,001 - $15,000 Oct 22, 2025
Thomas H. Kean House Buy $1,001 - $15,000 Oct 14, 2025
Valerie Hoyle House Buy $1,001 - $15,000 Sep 12, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
Thomas H. Kean House Buy $1,001 - $15,000 Jul 16, 2025
Jefferson Shreve House Sell $15,001 - $50,000 Jun 22, 2025